{
  "DOI": "10.1038/ejhg.2009.103",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2009.103",
  "alternative-id": [
    "BFejhg2009103"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "19 January 2009"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "27 April 2009"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "14 May 2009"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "8 July 2009"
    },
    {
      "label": "Free to read",
      "name": "free",
      "value": "This content has been made available to all."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Gazzerro",
      "given": "Elisabetta",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Sotgia",
      "given": "Federica",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bruno",
      "given": "Claudio",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lisanti",
      "given": "Michael P",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Minetti",
      "given": "Carlo",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2009,
        7,
        8
      ]
    ],
    "date-time": "2009-07-08T10:29:57Z",
    "timestamp": 1247048997000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T16:57:17Z",
    "timestamp": 1684429037000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        30
      ]
    ],
    "date-time": "2024-04-30T00:27:31Z",
    "timestamp": 1714436851648
  },
  "is-referenced-by-count": 166,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2009,
        7,
        8
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2010,
          2
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2009,
            7,
            8
          ]
        ],
        "date-time": "2009-07-08T00:00:00Z",
        "timestamp": 1247011200000
      }
    },
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2009,
            7,
            8
          ]
        ],
        "date-time": "2009-07-08T00:00:00Z",
        "timestamp": 1247011200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2009103.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2009103",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2009103.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "137-145",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2009,
        7,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2009,
        7,
        8
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2010,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1080/07853890410018899",
      "author": "TM Williams",
      "doi-asserted-by": "crossref",
      "first-page": "584",
      "journal-title": "Ann Med",
      "key": "BFejhg2009103_CR1",
      "unstructured": "Williams TM, Lisanti MP : The Caveolin genes: from cell biology to medicine. Ann Med 2004; 36: 584–595.",
      "volume": "36",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0955-0674(96)80033-0",
      "author": "RG Parton",
      "doi-asserted-by": "crossref",
      "first-page": "542",
      "journal-title": "Curr Opin Cell Biol",
      "key": "BFejhg2009103_CR2",
      "unstructured": "Parton RG : Caveolae and caveolins. Curr Opin Cell Biol 1996; 8: 542–548.",
      "volume": "8",
      "year": "1996"
    },
    {
      "DOI": "10.1073/pnas.93.1.131",
      "author": "PE Scherer",
      "doi-asserted-by": "crossref",
      "first-page": "131",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2009103_CR3",
      "unstructured": "Scherer PE, Okamoto T, Chun M, Nishimoto I, Lodish HF, Lisanti MP : Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA 1996; 93: 131–135.",
      "volume": "93",
      "year": "1996"
    },
    {
      "DOI": "10.1002/mus.20973",
      "author": "HJ Lee",
      "doi-asserted-by": "crossref",
      "first-page": "1021",
      "journal-title": "Muscle Nerve",
      "key": "BFejhg2009103_CR4",
      "unstructured": "Lee HJ, Park CH, Lee SJ et al: Expression of caveolin-3 immunoreactivities in the developing sciatic nerve of the rat. Muscle Nerve 2008; 38: 1021–1026.",
      "volume": "38",
      "year": "2008"
    },
    {
      "DOI": "10.1016/S1471-4914(01)02105-0",
      "author": "F Galbiati",
      "doi-asserted-by": "crossref",
      "first-page": "435",
      "journal-title": "Trends Mol Med",
      "key": "BFejhg2009103_CR5",
      "unstructured": "Galbiati F, Razani B, Lisanti MP : Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med 2001; 7: 435–441.",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1212/WNL.62.4.538",
      "author": "SE Woodman",
      "doi-asserted-by": "crossref",
      "first-page": "538",
      "journal-title": "Neurology.",
      "key": "BFejhg2009103_CR6",
      "unstructured": "Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP : Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology. 2004; 62: 538–543.",
      "volume": "62",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0002-9440(10)64370-2",
      "author": "C Minetti",
      "doi-asserted-by": "crossref",
      "first-page": "265",
      "journal-title": "Am J Pathol",
      "key": "BFejhg2009103_CR7",
      "unstructured": "Minetti C, Bado M, Broda P et al: Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Am J Pathol 2002; 160: 265–270.",
      "volume": "160",
      "year": "2002"
    },
    {
      "DOI": "10.1074/jbc.271.25.15160",
      "author": "KS Song",
      "doi-asserted-by": "crossref",
      "first-page": "15160",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR8",
      "unstructured": "Song KS, Scherer PE, Tang Z et al: Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996; 271: 15160–15165.",
      "volume": "271",
      "year": "1996"
    },
    {
      "DOI": "10.1016/S0014-5793(98)00442-6",
      "author": "RH Crosbie",
      "doi-asserted-by": "crossref",
      "first-page": "279",
      "journal-title": "FEBS Lett",
      "key": "BFejhg2009103_CR9",
      "unstructured": "Crosbie RH, Yamada H, Venzke DP, Lisanti MP, Campbell KP : Caveolin-3 is not an integral component of the dystrophin glycoprotein complex. FEBS Lett 1998; 427: 279–282.",
      "volume": "427",
      "year": "1998"
    },
    {
      "DOI": "10.1016/S0898-6568(01)00236-4",
      "author": "JL Ilsley",
      "doi-asserted-by": "crossref",
      "first-page": "183",
      "journal-title": "Cell Signal",
      "key": "BFejhg2009103_CR10",
      "unstructured": "Ilsley JL, Sudol M, Winder SJ : The WW domain: linking cell signalling to the membrane cytoskeleton. Cell Signal 2002; 14: 183–189.",
      "volume": "14",
      "year": "2002"
    },
    {
      "DOI": "10.1074/jbc.M005321200",
      "author": "F Sotgia",
      "doi-asserted-by": "crossref",
      "first-page": "38048",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR11",
      "unstructured": "Sotgia F, Lee JK, Das K et al: Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 2000; 275: 38048–38058.",
      "volume": "275",
      "year": "2000"
    },
    {
      "DOI": "10.1093/oxfordjournals.hmg.a018926",
      "author": "R Herrmann",
      "doi-asserted-by": "crossref",
      "first-page": "2335",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009103_CR12",
      "unstructured": "Herrmann R, Straub V, Blank M et al: Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet 2000; 9: 2335–2340.",
      "volume": "9",
      "year": "2000"
    },
    {
      "DOI": "10.1073/pnas.160249097",
      "author": "F Galbiati",
      "doi-asserted-by": "crossref",
      "first-page": "9689",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2009103_CR13",
      "unstructured": "Galbiati F, Volonte D, Chu JB et al: Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc Natl Acad Sci USA 2000; 97: 9689–9694.",
      "volume": "97",
      "year": "2000"
    },
    {
      "DOI": "10.1074/jbc.272.45.28187",
      "author": "VJ Venema",
      "doi-asserted-by": "crossref",
      "first-page": "28187",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR14",
      "unstructured": "Venema VJ, Ju H, Zou R, Venema RC : Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 1997; 272: 28187–28190.",
      "volume": "272",
      "year": "1997"
    },
    {
      "author": "PW Shaul",
      "first-page": "L843",
      "journal-title": "Am J Physiol",
      "key": "BFejhg2009103_CR15",
      "unstructured": "Shaul PW, Anderson RG : Role of plasmalemmal caveolae in signal transduction. Am J Physiol 1998; 275: L843–L851.",
      "volume": "275",
      "year": "1998"
    },
    {
      "DOI": "10.1046/j.0014-2956.2001.02715.x",
      "author": "LD Zajchowski",
      "doi-asserted-by": "crossref",
      "first-page": "737",
      "journal-title": "Eur J Biochem",
      "key": "BFejhg2009103_CR16",
      "unstructured": "Zajchowski LD, Robbins SM : Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur J Biochem 2002; 269: 737–752.",
      "volume": "269",
      "year": "2002"
    },
    {
      "DOI": "10.1128/MCB.22.11.3905-3926.2002",
      "author": "F Sotgia",
      "doi-asserted-by": "crossref",
      "first-page": "3905",
      "journal-title": "Mol Cell Biol",
      "key": "BFejhg2009103_CR17",
      "unstructured": "Sotgia F, Razani B, Bonuccelli G et al: Intracellular retention of glycosylphosphatidyl inositol-linked proteins in caveolin-deficient cells. Mol Cell Biol 2002; 22: 3905–3926.",
      "volume": "22",
      "year": "2002"
    },
    {
      "DOI": "10.1161/hh0402.105177",
      "author": "TL Yarbrough",
      "doi-asserted-by": "crossref",
      "first-page": "443",
      "journal-title": "Circ Res",
      "key": "BFejhg2009103_CR18",
      "unstructured": "Yarbrough TL, Lu T, Lee HC, Shibata EF : Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ Res 2002; 90: 443–449.",
      "volume": "90",
      "year": "2002"
    },
    {
      "DOI": "10.1074/jbc.M009948200",
      "author": "JR Martens",
      "doi-asserted-by": "crossref",
      "first-page": "8409",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR19",
      "unstructured": "Martens JR, Sakamoto N, Sullivan SA, Grobaski TD, Tamkun MM : Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J Biol Chem 2001; 276: 8409–8414.",
      "volume": "276",
      "year": "2001"
    },
    {
      "DOI": "10.1111/j.1749-6632.2002.tb04741.x",
      "author": "J Bossuyt",
      "doi-asserted-by": "crossref",
      "first-page": "197",
      "journal-title": "Ann NY Acad Sci",
      "key": "BFejhg2009103_CR20",
      "unstructured": "Bossuyt J, Taylor BE, James-Kracke M, Hale CC : The cardiac sodium-calcium exchanger associates with caveolin-3. Ann NY Acad Sci 2002; 976: 197–204.",
      "volume": "976",
      "year": "2002"
    },
    {
      "DOI": "10.1073/pnas.0503465103",
      "author": "RC Balijepalli",
      "doi-asserted-by": "crossref",
      "first-page": "7500",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2009103_CR21",
      "unstructured": "Balijepalli RC, Foell JD, Hall DD, Hell JW, Kamp TJ : Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. Proc Natl Acad Sci USA 2006; 103: 7500–7505.",
      "volume": "103",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.yjmcc.2006.09.018",
      "author": "A Barbuti",
      "doi-asserted-by": "crossref",
      "first-page": "71",
      "journal-title": "J Mol Cell Cardiol",
      "key": "BFejhg2009103_CR22",
      "unstructured": "Barbuti A, Terragni B, Brioschi C, DiFrancesco D : Localization of f-channels to caveolae mediates specific beta2-adrenergic receptor modulation of rate in sinoatrial myocytes. J Mol Cell Cardiol 2007; 42: 71–78.",
      "volume": "42",
      "year": "2007"
    },
    {
      "DOI": "10.1016/S0002-9440(10)63616-4",
      "author": "F Sotgia",
      "doi-asserted-by": "crossref",
      "first-page": "2619",
      "journal-title": "Am J Pathol",
      "key": "BFejhg2009103_CR23",
      "unstructured": "Sotgia F, Bonuccelli G, Minetti C et al: Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases. Am J Pathol 2003; 163: 2619–2634.",
      "volume": "163",
      "year": "2003"
    },
    {
      "DOI": "10.1096/fj.01-0646fje",
      "author": "M Karlsson",
      "doi-asserted-by": "crossref",
      "first-page": "249",
      "journal-title": "FASEB J",
      "key": "BFejhg2009103_CR24",
      "unstructured": "Karlsson M, Thorn H, Parpal S, Stralfors P, Gustavsson J : Insulin induces translocation of glucose transporter GLUT4 to plasma membrane caveolae in adipocytes. FASEB J 2002; 16: 249–251.",
      "volume": "16",
      "year": "2002"
    },
    {
      "DOI": "10.1074/jbc.272.33.20698",
      "author": "PE Scherer",
      "doi-asserted-by": "crossref",
      "first-page": "20698",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR25",
      "unstructured": "Scherer PE, Lisanti MP : Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes. Dynamic regulation by extracellular glucose and intracellular metabolites. J Biol Chem 1997; 272: 20698–20705.",
      "volume": "272",
      "year": "1997"
    },
    {
      "DOI": "10.1152/ajpheart.00387.2008",
      "author": "AS Augustus",
      "doi-asserted-by": "crossref",
      "first-page": "H657",
      "journal-title": "Am J Physiol Heart Circ Physiol",
      "key": "BFejhg2009103_CR26",
      "unstructured": "Augustus AS, Buchanan J, Addya S et al: Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts. Am J Physiol Heart Circ Physiol 2008; 295: H657–H666.",
      "volume": "295",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.bbrc.2007.03.148",
      "author": "A Fanzani",
      "doi-asserted-by": "crossref",
      "first-page": "314",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "BFejhg2009103_CR27",
      "unstructured": "Fanzani A, Musaro A, Stoppani E et al: Hypertrophy and atrophy inversely regulate Caveolin-3 expression in myoblasts. Biochem Biophys Res Commun 2007; 357: 314–318.",
      "volume": "357",
      "year": "2007"
    },
    {
      "DOI": "10.1074/jbc.274.42.30315",
      "author": "F Galbiati",
      "doi-asserted-by": "crossref",
      "first-page": "30315",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR28",
      "unstructured": "Galbiati F, Volonte D, Engelman JA, Scherer PE, Lisanti MP : Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J Biol Chem 1999; 274: 30315–30321.",
      "volume": "274",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.febslet.2007.09.055",
      "author": "A Fanzani",
      "doi-asserted-by": "crossref",
      "first-page": "5099",
      "journal-title": "FEBS Lett",
      "key": "BFejhg2009103_CR29",
      "unstructured": "Fanzani A, Stoppani E, Gualandi L et al: Phenotypic behavior of C2C12 myoblasts upon expression of the dystrophy-related caveolin-3 P104 L and TFT mutants. FEBS Lett 2007; 581: 5099–5104.",
      "volume": "581",
      "year": "2007"
    },
    {
      "DOI": "10.1093/hmg/ddi179",
      "author": "SJ Nixon",
      "doi-asserted-by": "crossref",
      "first-page": "1727",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009103_CR30",
      "unstructured": "Nixon SJ, Wegner J, Ferguson C et al: Zebrafish as a model for caveolin-associated muscle disease; caveolin-3 is required for myofibril organization and muscle cell patterning. Hum Mol Genet 2005; 14: 1727–1743.",
      "volume": "14",
      "year": "2005"
    },
    {
      "DOI": "10.1074/jbc.M100828200",
      "author": "F Galbiati",
      "doi-asserted-by": "crossref",
      "first-page": "21425",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR31",
      "unstructured": "Galbiati F, Engelman JA, Volonte D et al: Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem 2001; 276: 21425–21433.",
      "volume": "276",
      "year": "2001"
    },
    {
      "DOI": "10.1093/hmg/10.3.173",
      "author": "Y Sunada",
      "doi-asserted-by": "crossref",
      "first-page": "173",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009103_CR32",
      "unstructured": "Sunada Y, Ohi H, Hase A et al: Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity. Hum Mol Genet 2001; 10: 173–178.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1038/387083a0",
      "author": "AC McPherron",
      "doi-asserted-by": "crossref",
      "first-page": "83",
      "journal-title": "Nature",
      "key": "BFejhg2009103_CR33",
      "unstructured": "McPherron AC, Lawler AM, Lee SJ : Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83–90.",
      "volume": "387",
      "year": "1997"
    },
    {
      "DOI": "10.1002/gene.10188",
      "author": "L Grobet",
      "doi-asserted-by": "crossref",
      "first-page": "227",
      "journal-title": "Genesis",
      "key": "BFejhg2009103_CR34",
      "unstructured": "Grobet L, Pirottin D, Farnir F et al: Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene. Genesis 2003; 35: 227–238.",
      "volume": "35",
      "year": "2003"
    },
    {
      "DOI": "10.1097/01.fjc.0000152029.53997.57",
      "author": "T Kikuchi",
      "doi-asserted-by": "crossref",
      "first-page": "204",
      "journal-title": "J Cardiovasc Pharmacol",
      "key": "BFejhg2009103_CR35",
      "unstructured": "Kikuchi T, Oka N, Koga A, Miyazaki H, Ohmura H, Imaizumi T : Behavior of caveolae and caveolin-3 during the development of myocyte hypertrophy. J Cardiovasc Pharmacol 2005; 45: 204–210.",
      "volume": "45",
      "year": "2005"
    },
    {
      "DOI": "10.1161/01.HYP.0000082926.08268.5D",
      "author": "A Koga",
      "doi-asserted-by": "crossref",
      "first-page": "213",
      "journal-title": "Hypertension",
      "key": "BFejhg2009103_CR36",
      "unstructured": "Koga A, Oka N, Kikuchi T, Miyazaki H, Kato S, Imaizumi T : Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy. Hypertension 2003; 42: 213–219.",
      "volume": "42",
      "year": "2003"
    },
    {
      "DOI": "10.1093/hmg/ddh014",
      "author": "Y Ohsawa",
      "doi-asserted-by": "crossref",
      "first-page": "151",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009103_CR37",
      "unstructured": "Ohsawa Y, Toko H, Katsura M et al: Overexpression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity. Hum Mol Genet 2004; 13: 151–157.",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1074/jbc.M205511200",
      "author": "SE Woodman",
      "doi-asserted-by": "crossref",
      "first-page": "38988",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR38",
      "unstructured": "Woodman SE, Park DS, Cohen AW et al: Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 2002; 277: 38988–38997.",
      "volume": "277",
      "year": "2002"
    },
    {
      "DOI": "10.1152/ajpcell.00489.2004",
      "author": "F Capozza",
      "doi-asserted-by": "crossref",
      "first-page": "C1317",
      "journal-title": "Am J Physiol Cell Physiol",
      "key": "BFejhg2009103_CR39",
      "unstructured": "Capozza F, Combs TP, Cohen AW et al: Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol 2005; 288: C1317–C1331.",
      "volume": "288",
      "year": "2005"
    },
    {
      "DOI": "10.1152/ajpcell.00006.2003",
      "author": "AW Cohen",
      "doi-asserted-by": "crossref",
      "first-page": "C222",
      "journal-title": "Am J Physiol Cell Physiol",
      "key": "BFejhg2009103_CR40",
      "unstructured": "Cohen AW, Razani B, Wang XB et al: Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 2003; 285: C222–C235.",
      "volume": "285",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0014-5793(99)00658-4",
      "author": "F Sotgia",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "journal-title": "FEBS Lett",
      "key": "BFejhg2009103_CR41",
      "unstructured": "Sotgia F, Minetti C, Lisanti MP : Localization of the human caveolin-3 gene to the D3S18/D3S4163/D3S4539 locus (3p25), in close proximity to the human oxytocin receptor gene. Identification of the caveolin-3 gene as a candidate for deletion in 3p-syndrome. FEBS Lett 1999; 452: 177–180.",
      "volume": "452",
      "year": "1999"
    },
    {
      "DOI": "10.1093/hmg/7.5.871",
      "author": "EM McNally",
      "doi-asserted-by": "crossref",
      "first-page": "871",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009103_CR42",
      "unstructured": "McNally EM, de Sa Moreira E, Duggan DJ et al: Caveolin-3 in muscular dystrophy. Hum Mol Genet 1998; 7: 871–877.",
      "volume": "7",
      "year": "1998"
    },
    {
      "DOI": "10.1002/ana.10501",
      "author": "C Kubisch",
      "doi-asserted-by": "crossref",
      "first-page": "512",
      "journal-title": "Ann Neurol",
      "key": "BFejhg2009103_CR43",
      "unstructured": "Kubisch C, Schoser BG, von During M et al: Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease. Ann Neurol 2003; 53: 512–520.",
      "volume": "53",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.nmd.2006.04.006",
      "author": "JS Muller",
      "doi-asserted-by": "crossref",
      "first-page": "432",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg2009103_CR44",
      "unstructured": "Muller JS, Piko H, Schoser BG et al: Novel splice site mutation in the caveolin-3 gene leading to autosomal recessive limb girdle muscular dystrophy. Neuromuscul Disord 2006; 16: 432–436.",
      "volume": "16",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.nmd.2007.03.009",
      "author": "H Ueyama",
      "doi-asserted-by": "crossref",
      "first-page": "558",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg2009103_CR45",
      "unstructured": "Ueyama H, Horinouchi H, Obayashi K, Hashinaga M, Okazaki T, Kumamoto T : Novel homozygous mutation of the caveolin-3 gene in rippling muscle disease with extraocular muscle paresis. Neuromuscul Disord 2007; 17: 558–561.",
      "volume": "17",
      "year": "2007"
    },
    {
      "DOI": "10.1136/jnnp.2007.133207",
      "author": "M Traverso",
      "doi-asserted-by": "crossref",
      "first-page": "735",
      "journal-title": "J Neurol Neurosurg Psychiatry",
      "key": "BFejhg2009103_CR46",
      "unstructured": "Traverso M, Bruno C, Broccolini A et al: Truncation of Caveolin-3 causes autosomal-recessive Rippling Muscle Disease. J Neurol Neurosurg Psychiatry 2008; 79: 735–737.",
      "volume": "79",
      "year": "2008"
    },
    {
      "DOI": "10.1038/labinvest.3700713",
      "author": "M Traverso",
      "doi-asserted-by": "crossref",
      "first-page": "275",
      "journal-title": "Lab Invest",
      "key": "BFejhg2009103_CR47",
      "unstructured": "Traverso M, Gazzerro E, Assereto S et al: Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro. Lab Invest 2008; 88: 275–283.",
      "volume": "88",
      "year": "2008"
    },
    {
      "DOI": "10.1002/humu.20119",
      "author": "L Fulizio",
      "doi-asserted-by": "crossref",
      "first-page": "82",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2009103_CR48",
      "unstructured": "Fulizio L, Nascimbeni AC, Fanin M et al: Molecular and muscle pathology in a series of caveolinopathy patients. Hum Mutat 2005; 25: 82–89.",
      "volume": "25",
      "year": "2005"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.106.635268",
      "author": "M Vatta",
      "doi-asserted-by": "crossref",
      "first-page": "2104",
      "journal-title": "Circulation",
      "key": "BFejhg2009103_CR49",
      "unstructured": "Vatta M, Ackerman MJ, Ye B et al: Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006; 114: 2104–2112.",
      "volume": "114",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.hrthm.2006.11.030",
      "author": "LB Cronk",
      "doi-asserted-by": "crossref",
      "first-page": "161",
      "journal-title": "Heart Rhythm",
      "key": "BFejhg2009103_CR50",
      "unstructured": "Cronk LB, Ye B, Kaku T et al: Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm 2007; 4: 161–166.",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.nmd.2008.05.003",
      "author": "A Aboumousa",
      "doi-asserted-by": "crossref",
      "first-page": "572",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg2009103_CR51",
      "unstructured": "Aboumousa A, Hoogendijk J, Charlton R et al: Caveolinopathy--new mutations and additional symptoms. Neuromuscul Disord 2008; 18: 572–578.",
      "volume": "18",
      "year": "2008"
    },
    {
      "DOI": "10.1097/WCO.0b013e32830efdc2",
      "author": "M Guglieri",
      "doi-asserted-by": "crossref",
      "first-page": "576",
      "journal-title": "Curr Opin Neurol",
      "key": "BFejhg2009103_CR52",
      "unstructured": "Guglieri M, Straub V, Bushby K, Lochmuller H : Limb-girdle muscular dystrophies. Curr Opin Neurol 2008; 21: 576–584.",
      "volume": "21",
      "year": "2008"
    },
    {
      "DOI": "10.1002/humu.20642",
      "author": "M Guglieri",
      "doi-asserted-by": "crossref",
      "first-page": "258",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2009103_CR53",
      "unstructured": "Guglieri M, Magri F, D'Angelo MG et al: Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients. Hum Mutat 2008; 29: 258–266.",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ng0498-365",
      "author": "C Minetti",
      "doi-asserted-by": "crossref",
      "first-page": "365",
      "journal-title": "Nat Genet",
      "key": "BFejhg2009103_CR54",
      "unstructured": "Minetti C, Sotgia F, Bruno C et al: Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998; 18: 365–368.",
      "volume": "18",
      "year": "1998"
    },
    {
      "author": "L Kunkel",
      "first-page": "33",
      "journal-title": "J Child Neurol",
      "key": "BFejhg2009103_CR55",
      "unstructured": "Kunkel L : Caveolin-3 deficiency as a cause of limb-girdle muscular dystrophy. J Child Neurol 1999; 14: 33–34.",
      "volume": "14",
      "year": "1999"
    },
    {
      "DOI": "10.1093/hmg/10.17.1761",
      "author": "C Matsuda",
      "doi-asserted-by": "crossref",
      "first-page": "1761",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2009103_CR56",
      "unstructured": "Matsuda C, Hayashi YK, Ogawa M et al: The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet 2001; 10: 1761–1766.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1212/01.WNL.0000076486.57572.5C",
      "author": "D Figarella-Branger",
      "doi-asserted-by": "crossref",
      "first-page": "562",
      "journal-title": "Neurology",
      "key": "BFejhg2009103_CR57",
      "unstructured": "Figarella-Branger D, Pouget J, Bernard R et al: Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene. Neurology 2003; 61: 562–564.",
      "volume": "61",
      "year": "2003"
    },
    {
      "DOI": "10.1016/j.nmd.2004.08.008",
      "author": "K Sugie",
      "doi-asserted-by": "crossref",
      "first-page": "810",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg2009103_CR58",
      "unstructured": "Sugie K, Murayama K, Noguchi S et al: Two novel CAV3 gene mutations in Japanese families. Neuromuscul Disord 2004; 14: 810–814.",
      "volume": "14",
      "year": "2004"
    },
    {
      "DOI": "10.1212/WNL.62.4.538",
      "author": "SE Woodman",
      "doi-asserted-by": "crossref",
      "first-page": "538",
      "journal-title": "Neurology",
      "key": "BFejhg2009103_CR59",
      "unstructured": "Woodman SE, Sotgia F, Galbiati F, Minetti C, Lisanti MP : Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology 2004; 62: 538–543.",
      "volume": "62",
      "year": "2004"
    },
    {
      "DOI": "10.1002/mus.20092",
      "author": "DB Fee",
      "doi-asserted-by": "crossref",
      "first-page": "375",
      "journal-title": "Muscle Nerve",
      "key": "BFejhg2009103_CR60",
      "unstructured": "Fee DB, So YT, Barraza C, Figueroa KP, Pulst SM : Phenotypic variability associated with Arg26Gln mutation in caveolin3. Muscle Nerve 2004; 30: 375–378.",
      "volume": "30",
      "year": "2004"
    },
    {
      "DOI": "10.1002/ana.10442",
      "author": "D Fischer",
      "doi-asserted-by": "crossref",
      "first-page": "233",
      "journal-title": "Ann Neurol",
      "key": "BFejhg2009103_CR61",
      "unstructured": "Fischer D, Schroers A, Blumcke I et al: Consequences of a novel caveolin-3 mutation in a large German family. Ann Neurol 2003; 53: 233–241.",
      "volume": "53",
      "year": "2003"
    },
    {
      "DOI": "10.1212/WNL.54.6.1373",
      "author": "I Carbone",
      "doi-asserted-by": "crossref",
      "first-page": "1373",
      "journal-title": "Neurology",
      "key": "BFejhg2009103_CR62",
      "unstructured": "Carbone I, Bruno C, Sotgia F et al: Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000; 54: 1373–1376.",
      "volume": "54",
      "year": "2000"
    },
    {
      "DOI": "10.1002/mus.20593",
      "author": "JC Reijneveld",
      "doi-asserted-by": "crossref",
      "first-page": "656",
      "journal-title": "Muscle Nerve",
      "key": "BFejhg2009103_CR63",
      "unstructured": "Reijneveld JC, Ginjaar IB, Frankhuizen WS, Notermans NC : CAV3 gene mutation analysis in patients with idiopathic hyper-CK-emia. Muscle Nerve 2006; 34: 656–658.",
      "volume": "34",
      "year": "2006"
    },
    {
      "DOI": "10.1136/jnnp.73.1.65",
      "author": "L Merlini",
      "doi-asserted-by": "crossref",
      "first-page": "65",
      "journal-title": "J Neurol Neurosurg Psychiatry",
      "key": "BFejhg2009103_CR64",
      "unstructured": "Merlini L, Carbone I, Capanni C et al: Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry 2002; 73: 65–67.",
      "volume": "73",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.nmd.2004.01.006",
      "author": "L Alias",
      "doi-asserted-by": "crossref",
      "first-page": "321",
      "journal-title": "Neuromuscul Disord",
      "key": "BFejhg2009103_CR65",
      "unstructured": "Alias L, Gallano P, Moreno D et al: A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia. Neuromuscul Disord 2004; 14: 321–324.",
      "volume": "14",
      "year": "2004"
    },
    {
      "DOI": "10.1038/90050",
      "author": "RC Betz",
      "doi-asserted-by": "crossref",
      "first-page": "218",
      "journal-title": "Nat Genet",
      "key": "BFejhg2009103_CR66",
      "unstructured": "Betz RC, Schoser BG, Kasper D et al: Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001; 28: 218–219.",
      "volume": "28",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.jns.2005.11.032",
      "author": "MT Dotti",
      "doi-asserted-by": "crossref",
      "first-page": "61",
      "journal-title": "J Neurol Sci",
      "key": "BFejhg2009103_CR67",
      "unstructured": "Dotti MT, Malandrini A, Gambelli S, Salvadori C, De Stefano N, Federico A : A new missense mutation in caveolin-3 gene causes rippling muscle disease. J Neurol Sci 2006; 243: 61–64.",
      "volume": "243",
      "year": "2006"
    },
    {
      "DOI": "10.1212/WNL.57.12.2273",
      "author": "M Vorgerd",
      "doi-asserted-by": "crossref",
      "first-page": "2273",
      "journal-title": "Neurology",
      "key": "BFejhg2009103_CR68",
      "unstructured": "Vorgerd M, Ricker K, Ziemssen F et al: A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 2001; 57: 2273–2277.",
      "volume": "57",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.jns.2007.04.023",
      "author": "JS Bae",
      "doi-asserted-by": "crossref",
      "first-page": "275",
      "journal-title": "J Neurol Sci",
      "key": "BFejhg2009103_CR69",
      "unstructured": "Bae JS, Ki CS, Kim JW et al: A novel in-frame deletion in the CAV3 gene in a Korean patient with rippling muscle disease. J Neurol Sci 2007; 260: 275–278.",
      "volume": "260",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ana.20350",
      "author": "C Kubisch",
      "doi-asserted-by": "crossref",
      "first-page": "303",
      "journal-title": "Ann Neurol",
      "key": "BFejhg2009103_CR70",
      "unstructured": "Kubisch C, Ketelsen UP, Goebel I, Omran H : Autosomal recessive rippling muscle disease with homozygous CAV3 mutations. Ann Neurol 2005; 57: 303–304.",
      "volume": "57",
      "year": "2005"
    },
    {
      "DOI": "10.1002/mus.20781",
      "author": "PJ Lorenzoni",
      "doi-asserted-by": "crossref",
      "first-page": "258",
      "journal-title": "Muscle Nerve",
      "key": "BFejhg2009103_CR71",
      "unstructured": "Lorenzoni PJ, Scola RH, Vieira N, Vainzof M, Carsten AL, Werneck LC : A novel missense mutation in the caveolin-3 gene in rippling muscle disease. Muscle Nerve 2007; 36: 258–260.",
      "volume": "36",
      "year": "2007"
    },
    {
      "DOI": "10.1212/01.wnl.0000180963.85963.73",
      "author": "RE Madrid",
      "doi-asserted-by": "crossref",
      "first-page": "1301",
      "journal-title": "Neurology",
      "key": "BFejhg2009103_CR72",
      "unstructured": "Madrid RE, Kubisch C, Hays AP : Early-onset toe walking in rippling muscle disease due to a new caveolin-3 gene mutation. Neurology 2005; 65: 1301–1303.",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1177/088307380201700703",
      "author": "U Schara",
      "doi-asserted-by": "crossref",
      "first-page": "483",
      "journal-title": "J Child Neurol",
      "key": "BFejhg2009103_CR73",
      "unstructured": "Schara U, Vorgerd M, Popovic N, Schoser BG, Ricker K, Mortier W : Rippling muscle disease in childhood. J Child Neurol 2002; 17: 483–490.",
      "volume": "17",
      "year": "2002"
    },
    {
      "DOI": "10.1136/jnnp.2003.028217",
      "author": "PY Van den Bergh",
      "doi-asserted-by": "crossref",
      "first-page": "1349",
      "journal-title": "J Neurol Neurosurg Psychiatry",
      "key": "BFejhg2009103_CR74",
      "unstructured": "Van den Bergh PY, Gerard JM, Elosegi JA, Manto MU, Kubisch C, Schoser BG : Novel missense mutation in the caveolin-3 gene in a Belgian family with rippling muscle disease. J Neurol Neurosurg Psychiatry 2004; 75: 1349–1351.",
      "volume": "75",
      "year": "2004"
    },
    {
      "DOI": "10.1212/WNL.58.2.323",
      "author": "M Tateyama",
      "doi-asserted-by": "crossref",
      "first-page": "323",
      "journal-title": "Neurology",
      "key": "BFejhg2009103_CR75",
      "unstructured": "Tateyama M, Aoki M, Nishino I et al: Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 2002; 58: 323–325.",
      "volume": "58",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.jns.2008.09.009",
      "author": "P Gonzalez-Perez",
      "doi-asserted-by": "crossref",
      "first-page": "95",
      "journal-title": "J Neurol Sci",
      "key": "BFejhg2009103_CR76",
      "unstructured": "Gonzalez-Perez P, Gallano P, Gonzalez-Quereda L et al: Phenotypic variability in a Spanish family with a Caveolin-3 mutation. J Neurol Sci 2009; 276: 95–98.",
      "volume": "276",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.bbrc.2003.11.101",
      "author": "T Hayashi",
      "doi-asserted-by": "crossref",
      "first-page": "178",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "BFejhg2009103_CR77",
      "unstructured": "Hayashi T, Arimura T, Ueda K et al: Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 2004; 313: 178–184.",
      "volume": "313",
      "year": "2004"
    },
    {
      "DOI": "10.1212/01.WNL.0000097320.35982.03",
      "author": "R Cagliani",
      "doi-asserted-by": "crossref",
      "first-page": "1513",
      "journal-title": "Neurology",
      "key": "BFejhg2009103_CR78",
      "unstructured": "Cagliani R, Bresolin N, Prelle A et al: A CAV3 microdeletion differentially affects skeletal muscle and myocardium. Neurology 2003; 61: 1513–1519.",
      "volume": "61",
      "year": "2003"
    },
    {
      "DOI": "10.1034/j.1600-0404.2003.00083.x",
      "author": "I Yabe",
      "doi-asserted-by": "crossref",
      "first-page": "47",
      "journal-title": "Acta Neurol Scand",
      "key": "BFejhg2009103_CR79",
      "unstructured": "Yabe I, Kawashima A, Kikuchi S et al: Caveolin-3 gene mutation in Japanese with rippling muscle disease. Acta Neurol Scand 2003; 108: 47–51.",
      "volume": "108",
      "year": "2003"
    },
    {
      "DOI": "10.1074/jbc.M006657200",
      "author": "F Galbiati",
      "doi-asserted-by": "crossref",
      "first-page": "37702",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR80",
      "unstructured": "Galbiati F, Volonte D, Minetti C, Bregman DB, Lisanti MP : Limb-girdle muscular dystrophy (LGMD-1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. Treatment with proteasomal inhibitors blocks the dominant negative effect of LGMD-1C mutanta and rescues wild-type caveolin-3. J Biol Chem 2000; 275: 37702–37711.",
      "volume": "275",
      "year": "2000"
    },
    {
      "DOI": "10.1074/jbc.274.36.25632",
      "author": "F Galbiati",
      "doi-asserted-by": "crossref",
      "first-page": "25632",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR81",
      "unstructured": "Galbiati F, Volonte D, Minetti C, Chu JB, Lisanti MP : Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. J Biol Chem 1999; 274: 25632–25641.",
      "volume": "274",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.yexcr.2006.05.010",
      "author": "GM Smythe",
      "doi-asserted-by": "crossref",
      "first-page": "2816",
      "journal-title": "Exp Cell Res",
      "key": "BFejhg2009103_CR82",
      "unstructured": "Smythe GM, Rando TA : Altered caveolin-3 expression disrupts PI(3) kinase signaling leading to death of cultured muscle cells. Exp Cell Res 2006; 312: 2816–2825.",
      "volume": "312",
      "year": "2006"
    },
    {
      "DOI": "10.1172/JCI28520",
      "author": "Y Ohsawa",
      "doi-asserted-by": "crossref",
      "first-page": "2924",
      "journal-title": "J Clin Invest",
      "key": "BFejhg2009103_CR83",
      "unstructured": "Ohsawa Y, Hagiwara H, Nakatani M et al: Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. J Clin Invest 2006; 116: 2924–2934.",
      "volume": "116",
      "year": "2006"
    },
    {
      "DOI": "10.1074/jbc.M708776200",
      "author": "DJ Hernandez-Deviez",
      "doi-asserted-by": "crossref",
      "first-page": "6476",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2009103_CR84",
      "unstructured": "Hernandez-Deviez DJ, Howes MT, Laval SH, Bushby K, Hancock JF, Parton RG : Caveolin regulates endocytosis of the muscle repair protein, dysferlin. J Biol Chem 2008; 283: 6476–6488.",
      "volume": "283",
      "year": "2008"
    },
    {
      "DOI": "10.1212/WNL.53.5.1119",
      "author": "C Matsuda",
      "doi-asserted-by": "crossref",
      "first-page": "1119",
      "journal-title": "Neurology",
      "key": "BFejhg2009103_CR85",
      "unstructured": "Matsuda C, Aoki M, Hayashi YK, Ho MF, Arahata K, Brown Jr RH : Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy. Neurology 1999; 53: 1119–1122.",
      "volume": "53",
      "year": "1999"
    },
    {
      "DOI": "10.1038/labinvest.2009.23",
      "author": "I Mercier",
      "doi-asserted-by": "crossref",
      "first-page": "614",
      "journal-title": "Lab Invest",
      "key": "BFejhg2009103_CR86",
      "unstructured": "Mercier I, Jasmin JF, Pavlides S et al: Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders. Lab Invest 2009; 89: 614–623.",
      "volume": "89",
      "year": "2009"
    },
    {
      "DOI": "10.1016/S1535-6108(03)00168-5",
      "author": "JP Gratton",
      "doi-asserted-by": "crossref",
      "first-page": "31",
      "journal-title": "Cancer Cell",
      "key": "BFejhg2009103_CR87",
      "unstructured": "Gratton JP, Lin MI, Yu J et al: Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell 2003; 4: 31–39.",
      "volume": "4",
      "year": "2003"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-4082",
      "author": "MI Lin",
      "doi-asserted-by": "crossref",
      "first-page": "2849",
      "journal-title": "Cancer Res",
      "key": "BFejhg2009103_CR88",
      "unstructured": "Lin MI, Yu J, Murata T, Sessa WC : Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res 2007; 67: 2849–2856.",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.106.634709",
      "author": "JF Jasmin",
      "doi-asserted-by": "crossref",
      "first-page": "912",
      "journal-title": "Circulation",
      "key": "BFejhg2009103_CR89",
      "unstructured": "Jasmin JF, Mercier I, Dupuis J, Tanowitz HB, Lisanti MP : Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Circulation 2006; 114: 912–920.",
      "volume": "114",
      "year": "2006"
    }
  ],
  "reference-count": 89,
  "references-count": 89,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2009103"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Caveolinopathies: from the biology of caveolin-3 to human diseases"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "18"
}